Table GPS-8 part (i). Lifetime prevalence of drug use among all adults (15 to 64 years old) in nationwide surveys among the general population. Lifetime prevalence all adults (percentage): last survey available for each Member State

Country

Geographical area

Ref.

Year

Age range all adults

Sample size all adults

Cannabis (%)

Cocaine (%) (1)

Amphetamines (%) (2)

Ecstasy (%) (3)

LSD (%)

Belgium

National

5

2001

15-64

7347

10.6

 

2.1

 

 

Czech Republic

National

1

2002

18-64

2526

21.1

 

2.3

4.0

2.2

Denmark

National

3

2000

16-64

11825

31.3

2.5

5.9

1.0

1.4

Germany

National

6

2003

18-59

8061

24.5

3.2

3.4

2.4

2.5

Estonia

National

2

2003

 

 

 

 

 

 

 

Greece

National (except Aegean and Ionian Islands)

3

2004

15-64

4351

8.9

0.7

0.1

0.4

0.3

Spain

National

4

2001

15-64

14113

24.5

4.9

3.0

4.2

 

France

Metropolitan France

5

2002

15-64

1744

26.2

2.2

0.4

0.9

1.2

Ireland

National

4

2002-03

15-64

4925

17.6

3.1

3.0

3.8

3.0

Italy

National

2

2003

15-54

11869

22.4

4.6

1.9

1.8

2.1

Cyprus

National

1 (4)

2003

15-65

1000

19.8

1.1

1.4

4.3

0.2

Latvia

National

1

2003

15-64

 

10.6

1.2

2.6

2.4

1.1

Luxembourg

National

1

1998

15-64

 

12.9

0.2

 

1.2

1.4

Hungary

National

2

2003

18-54

 

9.8

1.0

2.5

3.1

1.7

Netherlands

National

2

2001

15-64

14045

21.0

3.6

3.1

3.6

1.3

Malta

National

1

2001

18-64

 

3.5

0.4

0.4

0.7

0.5

Poland

National

1

2002

16-64

 

7.7

0.8

1.9

0.7

1.2

Portugal

National

1

2001

15-64

14186

7.6

0.9

0.5

0.7

0.4

Slovakia

National

1

2002

18-64

1405

14.9

1.0

0.8

1.8

 

Finland

National

5

2002

15-64

2377

12.8

0.7

2.2

1.4

0.8

Sweden

National

5

2004

18-64

9514

13.8

 

 

  

 

United Kingdom

Northern Ireland

6

2002-03

15-64

3517

16.8

1.7

3.9

5.9

4.5

United Kingdom

England and Wales

8

2003-04

16-59

24422

30.8

6.8

12.2

6.9

6.1

Norway

National

1

1999

15-64

1803

15.3

2.2

3.8

1.3

 

Notes:  

(1) Cocaine any form.  

(2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine+ecstasy. 

(3) For Spain: ecstasy and other designer drugs.  

(4) Results of this survey should be viewed with caution due to important discrepancies with previous surveys and school surveys results. A new survey with a bigger sample is being conducted in 2005.  

This table aims to present national surveys. Exceptionally some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or big regions with urban and rural areas). Athens was included as reference point for 1993 survey.  

In surveys with small sample sizes results should be interpreted with caution.  

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.  

For methods and definitions on population surveys in general, see [Methods and definitions - prevalence and patterns of drug use in the general population].  

Sources: 

See [Table GPS-0] 

Data filter | gpstab09a-en.xml